Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis

Showing 15 posts of 823 posts found.

haseeb-ahmad-abpi-vice-president-4

ABPI names Novartis’ Haseeb Ahmad as new President

May 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Novartis, appointment, pharma

The Association of the British Pharmaceutical Industry (ABPI) has revealed the appointment of a new President: Haseeb Ahmad will assume …

Appointment
haseeb-ahmad-abpi-vice-president-4

ABPI names Novartis’ Haseeb Ahmad as new President

May 3, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Novartis, appointment, pharma

The Association of the British Pharmaceutical Industry (ABPI) has revealed the appointment of a new President: Haseeb Ahmad will assume …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

April 26, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aduro Biotech, Cancer, GSK, ICR, J&J, JJ, Novartis, Sandoz, pharma

The Institute for Cancer Research (ICR) called for new measures to increase the speed with which patients in the UK …

News
richard_saynor

Senior GSK exec Richard Saynor revealed as new Sandoz CEO

April 25, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Sandoz, appointment, pharma

Novartis has seen a major leadership change within its business, as the company announced that senior GlaxoSmithKline exec Richard Saynor …

News

Novartis reveals promising interim Phase 3 data for gene therapy Zolgensma in spinal muscular atrophy

April 18, 2019
Research and Development Novartis, Zolgensma, pharma

Novartis has revealed new interim data from its Phase 3 trial investigating the efficacy of its gene therapy Zolgensma (onasemnogene …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

April 18, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Genentech, Gilead, HIV, MS, Novartis, kidney disease, pharma

This week was a good one for clinical trials and a bad one for employees after both Gilead and GSK …

News
novartis_window

Novartis’ Kisqali combo rejected by NICE for advanced breast cancer

April 11, 2019
Sales and Marketing Kisqali, NHS, NICE, Novartis, pharma

Novartis’ Kisqali (ribociclib) has been rejected for use on the NHS by NICE for the treatment of advanced breast cancer, …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

April 5, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, AstraZeneca, Northern Ireland, Novartis, Placebo, UK, brexit, pharma

As Brexit looms, pharma trade lobby the ABPI called for a ban on exports of medicines in the case of …

News
novartis_outside_1

Novartis’ Cosentyx approved in China for plaque psoriasis

April 2, 2019
Manufacturing and Production, Sales and Marketing China, Cosentyx, Novartis, pharma, psoriasis

Novartis has revealed that its interleukin-17A (IL-17A) Cosentyx (secukinumab) has been authorised for use in China in the treatment of …

News

Novartis must face kickback allegations in court

April 2, 2019
Manufacturing and Production Novartis, US, government, kickbacks, prescriptions, whistle blower, whistle-blower

The US government has accused Novartis of paying doctors millions of dollars in kickbacks as part of a “company-wide kickback …

News
novartis_outside_1

Novartis inks $1.6 billion deal with immunology biotech IFM Therapeutics

April 1, 2019
Sales and Marketing Atlas Venture, Boston, IFM Therapeutics, Novartis, pharma

Swiss firm Novartis has agreed to pay a sum of $310 million upfront to Boston inflammation specialist IFM Therapeutics, as …

News
novartis_side_building

Novartis’ new MS drug to cost $88,000 a year

March 27, 2019
Research and Development, Sales and Marketing FDA, MS, Novartis, Novartis pharmaceuticals, multiple sclerosis

Paul Hudson, the CEO of Swiss firm Novartis Pharmaceuticals has said the company’s newly approved multiple sclerosis (MS) drug will …

News
richard-francis-big-image

Sandoz CEO Richard Francis to step down

March 14, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Novartis, Sandoz, appointment, pharma

Richard Francis is set to step down his role as Chief Executive of Novartis’ generics arm Sandoz after five years’ …

News

Scottish Medicines Consortium rejects Novartis’ CAR T therapy Kymriah

March 12, 2019
Manufacturing and Production Kymriah, NICE, Novartis, SMC, Scotland, UK

Scotland’s cost effectiveness body has refused to fund Novartis’ CAR T therapy Kymriah for adult patients with lymphoma. The Scottish …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

March 8, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Biogen, Gilead, HIV, Novartis, Scott Gottlieb, top 10

HIV hit the headlines this week after it was announced that a British man known only as the ‘London Patient’ …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025